Self-run tests detected MS worsening without relapses

Credibility

Interest

Share:1 min read

Key Takeaway

Patient reports and self-run tests identified MS worsening without reported relapses, though they only partly agreed with a doctor's disability rating.

What They Found

Over three years, about 45% of participants worsened on at least one patient report or self-run test. Of those who worsened, about 58% had no reported relapse. The tests covered walking speed, hand movements, and thinking speed. People whose reports or tests showed worsening also had more brain shrinkage and growing areas of damage on brain scans. They also reported poorer quality of life.

Who Should Care and Why

The study followed people with MS at multiple centers. It examined whether their own reports and self-run tests could capture worsening without a relapse. This matters because a person can get worse even when they report no flare-up. A smaller group also had a doctor's disability rating for comparison. The two ways of measuring worsening agreed only partly.

Important Considerations

The study followed 9,088 people over time, but only 279 were in the group used to compare results with a doctor's rating. Relapses were self-reported, so the findings depend on what participants reported. These results show links with brain scan changes and quality of life, not that the tests caused those changes.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News